Passa al contenuto
Merck

Patterns of genome evolution that have accompanied host adaptation in Salmonella.

Proceedings of the National Academy of Sciences of the United States of America (2014-12-24)
Gemma C Langridge, Maria Fookes, Thomas R Connor, Theresa Feltwell, Nicholas Feasey, Bryony N Parsons, Helena M B Seth-Smith, Lars Barquist, Anna Stedman, Tom Humphrey, Paul Wigley, Sarah E Peters, Duncan J Maskell, Jukka Corander, Jose A Chabalgoity, Paul Barrow, Julian Parkhill, Gordon Dougan, Nicholas R Thomson
ABSTRACT

Many bacterial pathogens are specialized, infecting one or few hosts, and this is often associated with more acute disease presentation. Specific genomes show markers of this specialization, which often reflect a balance between gene acquisition and functional gene loss. Within Salmonella enterica subspecies enterica, a single lineage exists that includes human and animal pathogens adapted to cause infection in different hosts, including S. enterica serovar Enteritidis (multiple hosts), S. Gallinarum (birds), and S. Dublin (cattle). This provides an excellent evolutionary context in which differences between these pathogen genomes can be related to host range. Genome sequences were obtained from ∼ 60 isolates selected to represent the known diversity of this lineage. Examination and comparison of the clades within the phylogeny of this lineage revealed signs of host restriction as well as evolutionary events that mark a path to host generalism. We have identified the nature and order of events for both evolutionary trajectories. The impact of functional gene loss was predicted based upon position within metabolic pathways and confirmed with phenotyping assays. The structure of S. Enteritidis is more complex than previously known, as a second clade of S. Enteritidis was revealed that is distinct from those commonly seen to cause disease in humans or animals, and that is more closely related to S. Gallinarum. Isolates from this second clade were tested in a chick model of infection and exhibited a reduced colonization phenotype, which we postulate represents an intermediate stage in pathogen-host adaptation.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
1,2-propandiolo, ≥99.5% (GC), FCC, FG
Sigma-Aldrich
1,2-propandiolo, ACS reagent, ≥99.5%
Sigma-Aldrich
Ethanolamine, ≥99%
Sigma-Aldrich
Ethanolamine, ≥98%
Sigma-Aldrich
Ethanolamine, purified by redistillation, ≥99.5%
Sigma-Aldrich
Propylene Glycol, meets USP testing specifications
Supelco
1,2-propandiolo, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Propilenglicole, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Ethanolamine, ACS reagent, ≥99.0%
Sigma-Aldrich
1,2-propandiolo, ReagentPlus®, 99%
Sigma-Aldrich
1,2-propandiolo, puriss. p.a., ACS reagent, ≥99.5% (GC)
Sigma-Aldrich
Ethanolamine, liquid, BioReagent, suitable for cell culture, ≥98%
Supelco
1,2-propandiolo, analytical standard
Supelco
Ethanolamine, analytical standard
Sigma-Aldrich
1,2-propandiolo, meets analytical specification of Ph. Eur., BP, USP, ≥99.5%
Supelco
Aucubin, analytical standard
1,2-propandiolo, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Ethanolamine, puriss. p.a., ACS reagent, ≥99.0% (GC/NT)
Sigma-Aldrich
1,2-propandiolo, tested according to Ph. Eur.
Trolamine impurity A, European Pharmacopoeia (EP) Reference Standard
Aucubin, primary reference standard